Primary antifungal prophylaxis in hematological malignancies. Updated clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL)

• Published in: Leukemia Vol. 39; no. 7; pp. 1547 - 1557
• Main Authors: Pagano, Livio, Maschmeyer, Georg, Lamoth, Frederic, Blennow, Ola, Xhaard, Alienor, Spadea, Manuela, Busca, Alessandro, Cordonnier, Catherine, Maertens, Johan
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 01.07.2025; Nature Publishing Group; Springer Nature
• Subjects: 692/308/174; 692/699/255/1672; Acute myeloid leukemia; Antifungal Agents - therapeutic use; Aspergillosis; Azacytidine; Bispecific antibodies; Cancer Research; Caspofungin; Chemotherapy; Chronic lymphocytic leukemia; Clinical medicine; Critical Care Medicine; Disease prevention; Drug interactions; Epidemiology; Evidence-based medicine; Fungal diseases; Fungicides; Guidelines; Health services; Hematologic Neoplasms - complications; Hematologic Neoplasms - therapy; Hematology; Hematopoietic stem cells; Hodgkin's lymphoma; Humans; Induction therapy; Infections; Intensive; Internal Medicine; Leukemia; Life Sciences; Lymphocytes; Lymphocytes T; Lymphoma; Malignancy; Medicine; Medicine & Public Health; Micafungin; Mold; Multiple myeloma; Mycoses - etiology; Mycoses - prevention & control; Myelodysplastic syndrome; Neoplasms; Oncology; Patients; Pediatrics; Posaconazole; Practice Guidelines as Topic; Prophylaxis; Remission; Remission (Medicine); Review; Review Article; Risk; Stem cell transplantation; Stem cells; Working groups

At the 10th European Conference on Infections in Leukaemia (ECIL), the guidelines for antifungal prophylaxis in pediatric and adult patients with hematological malignancies (HM) were updated and some changes introduced. Regarding acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) patie...